CSIMarket


Usana Health Sciences Inc   (USNA)
Other Ticker:  
 

Usana Health Sciences Inc

USNA's Fundamental analysis








Usana Health Sciences Inc 's sales fell by -8.11 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1996

Legal Cannabis industry recorded deterioration of revenues by -2.55 %

Usana Health Sciences Inc 's net profit deacreased by -10.04 % in I. Quarter 2024 year on year, to $17 millions.

More on USNA's Growth


Usana Health Sciences Inc
current PE on trailing twelve month basis is above Legal Cannabis industry average.

Company is currently trading with Price to Cash flow multiple of 27.54 in trailing twelve-month period. Legal Cannabis industry recorded net loss in trailing twelve months.
Company
14.57
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.
Legal Cannabis industry's Price to Sales ratio is at 10.16.


More on USNA's Valuation
 
 Total Debt (Millions $) 1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 503,471
 Net Income/Employee (TTM) $ 34,643
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 23.52

Usana Health Sciences Inc
current PE on trailing twelve month basis is above Legal Cannabis industry average.

Company is currently trading with Price to Cash flow multiple of 27.54 in trailing twelve-month period. Legal Cannabis industry recorded net loss in trailing twelve months.
Company
14.57
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.
Legal Cannabis industry's Price to Sales ratio is at 10.16.

Usana Health Sciences Inc Price to Book Ratio is at 1.8 lower than Indusry Avg. of 693.32. and higher than S&P 500 Avg. of 0.01

More on USNA's Valuation

  Market Capitalization (Millions $) 902
  Shares Outstanding (Millions) 19
  Employees 1,788
  Revenues (TTM) (Millions $) 900
  Net Income (TTM) (Millions $) 62
  Cash Flow (TTM) (Millions $) 33
  Capital Exp. (TTM) (Millions $) -16
  Total Debt (Millions $) 1
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 503,471
  Net Income/Employee(TTM) $ 34,643
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 23.52

  Market Capitalization (Millions $) 902
  Shares Outstanding (Millions) 19
  Employees 1,788
  Revenues (TTM) (Millions $) 900
  Net Income (TTM) (Millions $) 62
  Cash Flow (TTM) (Millions $) 33
  Capital Exp. (TTM) (Millions $) -16


    USNA's Profitability Comparisons
Usana Health Sciences Inc faced margin deterioraten, primarily through cost control. Operating Margin fell in I. Quarter 2024 to 10.83 % from 10.92 % in IV. Quarter.

Usana Health Sciences Inc net profit margin of 7.26 % is currently ranking no. 2 in Legal Cannabis industry, ranking no. 46 in Consumer Non Cyclical sector and number 1241 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 3.74
  Total Debt to Equity (MRQ) 0
  Tangible Leverage Ratio (MRQ) 0.25
  Asset Turnover Ratio (TTM) 1.49
  Inventory Turnover Ratio (TTM) 2.8



Usana Health Sciences Inc faced margin deterioraten, primarily through cost control. Operating Margin fell in I. Quarter 2024 to 10.83 % from 10.92 % in IV. Quarter.

Usana Health Sciences Inc net profit margin of 7.26 % is currently ranking no. 2 in Legal Cannabis industry, ranking no. 46 in Consumer Non Cyclical sector and number 1241 in S&P 500.

More on USNA's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com